These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29021778)

  • 1. The Combined Quantification and Interpretation of Multiple Quantitative Magnetic Resonance Imaging Metrics Enlightens Longitudinal Changes Compatible with Brain Repair in Relapsing-Remitting Multiple Sclerosis Patients.
    Bonnier G; Maréchal B; Fartaria MJ; Falkowskiy P; Marques JP; Simioni S; Schluep M; Du Pasquier R; Thiran JP; Krueger G; Granziera C
    Front Neurol; 2017; 8():506. PubMed ID: 29021778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Personalized pathology maps to quantify diffuse and focal brain damage.
    Bonnier G; Fischi-Gomez E; Roche A; Hilbert T; Kober T; Krueger G; Granziera C
    Neuroimage Clin; 2019; 21():101607. PubMed ID: 30502080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep gray matter changes in relapsing-remitting multiple sclerosis detected by multi-parametric, high-resolution magnetic resonance imaging (MRI).
    Al-Radaideh A; Athamneh I; Alabadi H; Hbahbih M
    Eur Radiol; 2021 Feb; 31(2):706-715. PubMed ID: 32851443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
    Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
    Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
    NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced MRI unravels the nature of tissue alterations in early multiple sclerosis.
    Bonnier G; Roche A; Romascano D; Simioni S; Meskaldji D; Rotzinger D; Lin YC; Menegaz G; Schluep M; Du Pasquier R; Sumpf TJ; Frahm J; Thiran JP; Krueger G; Granziera C
    Ann Clin Transl Neurol; 2014 Jun; 1(6):423-32. PubMed ID: 25356412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
    York EN; Thrippleton MJ; Meijboom R; Hunt DPJ; Waldman AD
    Brain Commun; 2022; 4(2):fcac088. PubMed ID: 35652121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up study.
    Mesaros S; Rocca M; Sormani M; Valsasina P; Markowitz C; De Stefano N; Montalban X; Barkhof F; Ranjeva J; Sailer M; Kappos L; Comi G; Filippi M
    Mult Scler; 2010 Mar; 16(3):325-31. PubMed ID: 20086023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical quantitative MRI parameters are related to the cognitive status in patients with relapsing-remitting multiple sclerosis.
    van Wijnen A; Petrov F; Maiworm M; Frisch S; Foerch C; Hattingen E; Steinmetz H; Klein JC; Deichmann R; Wagner M; Gracien RM
    Eur Radiol; 2020 Feb; 30(2):1045-1053. PubMed ID: 31602513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TI-relaxation time changes over five years in relapsing-remitting multiple sclerosis.
    Papadopoulos K; Tozer DJ; Fisniku L; Altmann DR; Davies G; Rashid W; Thompson AJ; Miller DH; Chard DT
    Mult Scler; 2010 Apr; 16(4):427-33. PubMed ID: 20086026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
    Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal quantitative MRI assessment of cortical damage in multiple sclerosis: A pilot study.
    Gracien RM; Reitz SC; Hof SM; Fleischer V; Droby A; Wahl M; Steinmetz H; Groppa S; Deichmann R; Klein JC
    J Magn Reson Imaging; 2017 Nov; 46(5):1485-1490. PubMed ID: 28240801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human brain atlas-based multimodal MRI analysis of volumetry, diffusimetry, relaxometry and lesion distribution in multiple sclerosis patients and healthy adult controls: implications for understanding the pathogenesis of multiple sclerosis and consolidation of quantitative MRI results in MS.
    Hasan KM; Walimuni IS; Abid H; Datta S; Wolinsky JS; Narayana PA
    J Neurol Sci; 2012 Feb; 313(1-2):99-109. PubMed ID: 21978603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.
    Simioni S; Amarù F; Bonnier G; Kober T; Rotzinger D; Du Pasquier R; Schluep M; Meuli R; Sbarbati A; Thiran JP; Krueger G; Granziera C
    J Neurol; 2014 Aug; 261(8):1606-13. PubMed ID: 24912471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F; Absinta M; Sormani MP; Ghezzi A; Bertolotto A; Montanari E; Comi G; Filippi M
    Brain; 2007 Aug; 130(Pt 8):2211-9. PubMed ID: 17535835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study of brain atrophy and cognitive disturbances in the early phase of relapsing-remitting multiple sclerosis.
    Zivadinov R; Sepcic J; Nasuelli D; De Masi R; Bragadin LM; Tommasi MA; Zambito-Marsala S; Moretti R; Bratina A; Ukmar M; Pozzi-Mucelli RS; Grop A; Cazzato G; Zorzon M
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):773-80. PubMed ID: 11385012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.